The largest database of trusted experimental protocols

30 protocols using flow count beads

1

Antiproliferative Potency of Novel Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 11

TABLE 7
Antiproliferative activity in human MT-2 leukemic cells in vitro
CC50, 50% Cytotoxic
concentration μMMT2
Compoundcells T cell leukemia
Bn-ODE-PMEG0.036 ± 0.04
Bn-ODE-PMEG slow<0.01
Bn-ODE-PMEG fast<0.01
Bn-ODE-PMEA<0.010

Method of cytotoxicity determination. MT-2 cells were incubated with drug for 72 hrs and harvested. Flow count beads (Beckman Coulter, Miami, Fla.) were added to the cell suspension followed by propidium iodide staining and analysis using flow cytometer and the 50% cytotoxic concentration (CC50) was calculated from the cell counts and viability.

Results. Compounds disclosed herein are effective antiproliferative agents in human T cell leukemia (MT-2) cells (Table 7).

+ Open protocol
+ Expand
2

Basophil and Neutrophil Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The flow cytometer was controlled daily using Flow‐Check (Beckman Coulter), and the stability of the compensations was examined daily using Flow‐Set (Beckman Coulter).
The absolute number of basophils and neutrophils was analysed. One hundred μl of whole blood was treated with the ImmunoPrep Reagent System (Beckman Coulter, USA) according to the manufacturer's instructions. Thereafter, the pretreated whole blood was mixed with 100 μl Flow‐Count beads (Beckman Coulter, USA), and the samples were analysed using flow cytometry, and the total number of leucocytes was counted.
Further, basophils were identified as CD203c+, CD193+ (Figure 1A,B) and neutrophils as CD15+, CD16+ (Figure 1C,D). Mean fluorescence intensity (MFI) was used to evaluate activation of basophils and neutrophils by expression of CD62L, CD11b and CD49d. In addition, basophil activation was also measured as MFI for CD203c and per cent positive CD63 basophils (%CD63+). A cut‐off for a negative test was set to a baseline CD63 expression of approximately 2·5%.
+ Open protocol
+ Expand
3

Quantifying Viable Cell Density

Check if the same lab product or an alternative is used in the 5 most similar protocols
To remove IL-3 from the original culture medium, the cells were washed two times by PBS(-) and then seeded into 24-well plates at a density of 1 × 105 cells/ml in the RPMI medium supplemented with/without 50 nM AP20187 under 37℃ in a 5% CO2 incubator. Viable cell density was measured after 3 day-incubation in flow cytometry as follows. The cell suspension (100 µl) was transferred to 96-well plates, in which 1 μg/ml propidium iodide, 4 µl Flow-Count beads (Beckman Coulter, Brea, CA), and 46 µl PBS were added to each well in advance. The number of cells was measured using a FACSCalibur flow cytometer (Becton–Dickinson, Franklin Lakes, NJ). Viable cells were identified as propidium iodide-negative cells using FlowJo software (Becton–Dickinson).
+ Open protocol
+ Expand
4

Cytotoxicity Determination in T-cell Leukemia

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 24

Method of Cytotoxicity Determination.

MT-2 cells were incubated with drug for 72 hrs and harvested. Flow count beads (Beckman Coulter, Miami, Fla.) were added to the cell suspension followed by propidium iodide staining and analysis using flow cytometer and the 50% cytotoxic concentration (CC50) was calculated from the cell counts and viability.

Results.

Compounds disclosed herein are effective antiproliferative agents in human T cell leukemia (MT-2) cells (Table 12).

TABLE 12
Antiproliferative activity in human MT-2 leukemic cells in vitro
CC50, 50% Cytotoxic concentration
Compound #μMMT2 cells T cell leukemia
10.036 ± 0.04
1a<0.01
1b<0.01
2<0.010

+ Open protocol
+ Expand
5

Quantifying Platelet-like Particle Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fixed cells or PLP were analyzed by flow cytometry using anti-CD61-PE (Invitrogen, Carlsbad, CA) antibodies. The PLP production capacity was defined using flow count beads (Beckman Coulter, Brea, CA) as an internal control. In total, 5 × 104 flow count beads were added to each sample. The number of YFP+CD61+ events with forward/side scatter (FSC/SSC) properties as human peripheral blood platelets per 2,000 units of flow count were enumerated. The number of PLP per cell was calculated by the following equation: PLP density (event/μl) = the concentration of flow count x number of PLP/number of beads x the volume of flow count/the volume of PLP suspension. Absolute number of PLP per YFP- and CD61-double-positive cells = PLP density x total PLP volume / number of plated YFP-positive cells. PLP size was recorded as the GeoMean of FSC in FACS analysis.
+ Open protocol
+ Expand
6

Basophil Enumeration in Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
The absolute number of basophils was estimated in 100 μL of whole blood by using the ImmunoPrep reagent system (Beckman Coulter) according to manufacturer's instructions. Subsequently, 100 μL of pretreated whole blood was mixed with 100 μL flow-count beads (Beckman Coulter) before flow cytometric analysis.
+ Open protocol
+ Expand
7

Competitive Homing and Trafficking Assay for T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Competitive short-term (1 h) homing assays were performed by co-mixing (1:1 ratio) 2.5 × 107 murine CD8+ T cells labeled with 5 - (and 6) - carboxyfluorescein diacetate succinimidyl ester (CFSE) with equal numbers of murine CD8+ T cells labeled with 5 - (and 6) - (4 -chloromethyl) benzoyl) amino) tetramethylrhodamine (CellTracker Orange, Invitrogen Life Technologies) prior to i.v. adoptive transfer. In homing studies using ex vivo activated human T cells, ~1.5 × 107 of CFSE- or CTO-labeled cells were mixed at equivalent numbers prior to injection into tumor-bearing mice. Tumor and spleen were collected 1 h later and mechanically dissociated by Medimachine (BD Biosciences) or passed through a 70 μm nylon cell strainer (BD Biosciences). Ratios of fluorescent adoptively-transferred cells were determined by flow cytometry, and total cell numbers were assessed using Flow Count Beads (Beckman Coulter)14 (link). In selected experiments intratumoral infiltration by OT-I cells was monitored using tracking dyes (CellVue Claret, Sigma Aldrich) or by congenic mismatch (CD45.1+ OT-I→CD45.2+ host) up to 3 weeks after transfer.
+ Open protocol
+ Expand
8

Effector T Cell Chemotaxis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemotaxis of murine and human effector T cells was assayed in 24 well plates (5 μM pore size transwell insert with polycarbonate membranes; Corning). Media alone (RPMI1640 + 1%BSA) or media containing recombinant chemokines (Peprotech) was placed at the bottom of triplicate wells. Murine T cell migration was assessed at 10 nM murine CXCL10, 1 nM murine CCL2, and 10 nM murine CCL5; human T cell chemotaxis was determined at 100 ng/mL recombinant human or murine chemokine20 (link) unless otherwise indicated. 5 × 105 cells were fluorescently labeled with CFSE or CTO, placed on the transwell insert, and incubated at 37°C for 3 h. Cells in the bottom chamber were enumerated by flow cytometry using Flow Count Beads (Beckman Coulter). Spontaneous migration was subtracted from all conditions, and data are reported either as absolute number of cells migrated or as migration relative to WT T cells.
+ Open protocol
+ Expand
9

Tumor-Infiltrating Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor-infiltrating cells were prepared with a tumor dissociation kit (Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer’s instructions. The total number of live cells analyzed was matched between the groups with Flow Count beads (Beckman Coulter, Fullerton, CA, USA). A Zombie Yellow fixable viability kit (BioLegend, San Diego, CA, USA) was used to stain dead cells. The cells were then pretreated with purified anti-mouse CD16/32 (2.4G2) (BD Biosciences, NJ, USA), stained with antibodies, and analyzed with a CytoFLEX (V5-B5-R3 configuration, Beckman Coulter, Fullerton, CA, USA). The following fluorescent-labeled antibodies were purchased from BioLegend (San Diego, CA, USA) and used for analysis: Brilliant Violet 785-conjugated anti-CD45 (30-F11), Brilliant Violet 605-conjugated anti CD11b (M1/70), allophycocyanin (APC)-conjugated anti-F4/80 (BM8), phycoerythrin (PE)-Cyanine7-conjugated anti-CD86 (GL-1), PE-conjugated anti-CD206 (MMR), and fluorescein isothiocyanate (FITC)-conjugated anti-CD49b (HMα2). For all channels, positive and negative cells were gated on the basis of fluorescence minus one controls, and CD86 and CD206 were gated with appropriate isotype controls (Figure S1). The data were analyzed with FlowJo software v10.4.
+ Open protocol
+ Expand
10

Cell Proliferation Assay with Apoptosis Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subcultured cells were washed with PBS twice to remove IL-3 in the culture medium. Cells were seeded into 24-well plates at 1 × 105 cells/ml with or without serial concentrations of AP20187 or Nutlin-3 (FUJIFILM Wako Pure Chemical) for 72 h. Flow cytometry was employed for cell counting. Before measurement, the sample mixtures (100 µl of cell suspension mixed with 4 µl of Flow-Count beads (Beckman Coulter, Brea, CA) and 46 µl of PBS containing 1 µg/ml of propidium iodide (Sigma‐Aldrich) at a final concentration) were transferred to 96-well plates and the number of cells was counted with a FACSCalibur flow cytometer (Becton–Dickinson, Franklin Lakes, NJ) calibrated by the count of Flow-Count beads. The data was processed by the software FlowJo v7.6.5 (Becton–Dickinson). The EC50 values of the helper ligand was calculated based on the results of the proliferation assay by curve fitting to the logistic function (Rodbard) using the software ImageJ v1.53 (National Institutes of Health, Bethesda, MD). The EC50 values were listed with the previously reported in vitro affinity values (Supplementary Fig. S3a).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!